drug

haloperidol

1 story · latest Nov 2, 2026

Follow haloperidol. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved · NDA020074

Timeline

BioMarin posts first $1 billion quarter, sets VOXZOGO PDUFA date for hypochondroplasia

Nov 2Quarterly updateBiomarin Pharmaceutical Inc vosoritide

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.